Estimating The Fair Value Of Corcept Therapeutics Incorporated (NASDAQ:CORT)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Corcept Therapeutics Incorporated (NASDAQ:CORT) as an investment opportunity by estimating the company
Corcept Therapeutics (NASDAQ:CORT) Downgraded by StockNews.com to "Buy"
StockNews.com downgraded shares of Corcept Therapeutics (NASDAQ:CORT – Get Rating) from a strong-buy rating to a buy rating in a research report report published on Monday morning. Separately, HC Wai
Stock Analysts' Downgrades for January 30th (ADM, BAH, BBSI, BMI, BSET, CDW, CORT, DEO, EW, HBAN)
Stock Analysts' downgrades for Monday, January 30th: Archer-Daniels-Midland (NYSE:ADM) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating. Get Archer-Daniels-Midla
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 4.9%
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating)'s share price fell 4.9% on Tuesday . The company traded as low as $22.99 and last traded at $22.99. 349,104 shares changed hands during mi
Estimating The Intrinsic Value Of Corcept Therapeutics Incorporated (NASDAQ:CORT)
Corcept Therapeutics (NASDAQ:CORT) Lowered to "Buy" at StockNews.com
Corcept Therapeutics (NASDAQ:CORT – Get Rating) was downgraded by investment analysts at StockNews.com from a "strong-buy" rating to a "buy" rating in a note issued to investors on Tuesday. Separatel
Hussman Strategic Advisors Inc. Sells 15,500 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)
Hussman Strategic Advisors Inc. reduced its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating) by 11.1% in the 3rd quarter, according to its most recent filing with t
Here's Why We Think Corcept Therapeutics (NASDAQ:CORT) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments
Robeco Institutional Asset Management B.V. Trims Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)
Robeco Institutional Asset Management B.V. lessened its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating) by 15.6% during the third quarter, according to the company
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. cut its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Rating) by 15.6% in the third quarter, according to its most recent disc
Loading...
No Stock Yet